title: Completion rate and compliance of anti-tuberculosis chemoprophylaxis in patients with rheumatic disease receiving tumor necrosis factor antagonists.
authors.forename: H
authors.initials: H
authors.lastname: Ideguchi
authors.forename: S
authors.initials: S
authors.lastname: Ohno
authors.forename: K
authors.initials: K
authors.lastname: Takase
authors.forename: Y
authors.initials: Y
authors.lastname: Kirino
authors.forename: A
authors.initials: A
authors.lastname: Suda
authors.forename: A
authors.initials: A
authors.lastname: Ihata
authors.forename: A
authors.initials: A
authors.lastname: Ueda
authors.forename: M
authors.initials: M
authors.lastname: Takeno
authors.forename: S
authors.initials: S
authors.lastname: Nagaoka
authors.forename: Y
authors.initials: Y
authors.lastname: Ishigatsubo
mesh_terms: D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance / Q000706:statistics & numerical data*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D018501:Antirheumatic Agents; D000995:Antitubercular Agents; D014409:Tumor Necrosis Factor-alpha